A retrospective study from South Korea [29] reported that ALK rearrangement was not associated with overall survival in lung adenocarcinoma patients who were never-smokers (P = 0.720), but disease-free survival was shorter in ALK-positive patients (P = 0.022). The gene discussed is ALK; the disease is lung adenocarcinoma.